Photo: depositphotos.com
Feb 4, 2026, 16:55
Bhavesh Thakkar: The Most Dangerous Assumption About Aspirin Is That It’s “Simple”
Bhavesh Thakkar, Clinical Pharmacist Intern at Fortis Healthcare, shared a post on LinkedIn:
”The most dangerous assumption we make about Aspirin? That it’s ‘simple.’
During my rotations at Fortis, I’ve realized that Aspirin is perhaps the most misunderstood drug on the shelf.
We often treat it as a basic NSAID. But the data tells a much more complex story.
From ancient willow bark to the modern debates on primary prevention, the ‘Story of Aspirin’ is actually a lesson in how evidence-based medicine evolves.
I put together this timeline to track that journey.
Inside this breakdown:
- The ‘Willow Bark’ origins (long before Bayer).
- How it changed the way we treat inflammation.
- The shift in guidelines: Why ‘routine’ use is now being questioned.
- Slide 12 was the biggest realization for me regarding the risk/benefit ratio in modern practice.
Pharmacists and Medics:
When do you still recommend Aspirin for primary prevention? Or have you stopped completely?”

Stay informed with Hemostasis Today.
-
Mar 21, 2026, 17:22Sean Lybrand: Supporting Children with ALL with ACT 4 Children in Armenia
-
Mar 21, 2026, 17:14Shira Roth: Candidate Biomarkers to Predict Post-Surgical VTE in Mesothelioma
-
Mar 21, 2026, 17:09Peter Antevy: Revealing How SWiFT Is Highlighting Prehospital System Limitations
-
Mar 21, 2026, 17:07Wolfgang Miesbach: Clinical Evidence for Newly Approved Fibrinogen Concentrate in Congenital Fibrinogen Deficiency
-
Mar 21, 2026, 17:07Archil Jaliashvili: NATO Blood Panel Warns That The System Won’t Hold Under Real Surge Conditions
-
Mar 21, 2026, 16:59Athanasios Frydas: Is It Safe to Skip TEE Before Rhythm Control in Low Thromboembolic Risk Patients?
-
Mar 21, 2026, 16:56Kalyan Roy: LTOWB as a Practical Approach to Rapid Transfusion in Major Bleeding
-
Mar 21, 2026, 16:47Francisco Chacón-Lozsán: Insights on Intermediate High Risk Pulmonary Embolism from ACVC 2026
-
Mar 21, 2026, 16:38Tarik Elagha: Should You Have Lp(a) Checked?